199 related articles for article (PubMed ID: 26320871)
1. Cancer Driver Log (CanDL): Catalog of Potentially Actionable Cancer Mutations.
Damodaran S; Miya J; Kautto E; Zhu E; Samorodnitsky E; Datta J; Reeser JW; Roychowdhury S
J Mol Diagn; 2015 Sep; 17(5):554-9. PubMed ID: 26320871
[TBL] [Abstract][Full Text] [Related]
2. OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers.
Wang T; Ruan S; Zhao X; Shi X; Teng H; Zhong J; You M; Xia K; Sun Z; Mao F
Nucleic Acids Res; 2021 Jan; 49(D1):D1289-D1301. PubMed ID: 33179738
[TBL] [Abstract][Full Text] [Related]
3. Exploring preferred amino acid mutations in cancer genes: Applications to identify potential drug targets.
Anoosha P; Sakthivel R; Michael Gromiha M
Biochim Biophys Acta; 2016 Feb; 1862(2):155-65. PubMed ID: 26581171
[TBL] [Abstract][Full Text] [Related]
4. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
5. The Candidate Cancer Gene Database: a database of cancer driver genes from forward genetic screens in mice.
Abbott KL; Nyre ET; Abrahante J; Ho YY; Isaksson Vogel R; Starr TK
Nucleic Acids Res; 2015 Jan; 43(Database issue):D844-8. PubMed ID: 25190456
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Characterization of Cancer Driver Genes and Mutations.
Bailey MH; Tokheim C; Porta-Pardo E; Sengupta S; Bertrand D; Weerasinghe A; Colaprico A; Wendl MC; Kim J; Reardon B; Ng PK; Jeong KJ; Cao S; Wang Z; Gao J; Gao Q; Wang F; Liu EM; Mularoni L; Rubio-Perez C; Nagarajan N; Cortés-Ciriano I; Zhou DC; Liang WW; Hess JM; Yellapantula VD; Tamborero D; Gonzalez-Perez A; Suphavilai C; Ko JY; Khurana E; Park PJ; Van Allen EM; Liang H; ; ; Lawrence MS; Godzik A; Lopez-Bigas N; Stuart J; Wheeler D; Getz G; Chen K; Lazar AJ; Mills GB; Karchin R; Ding L
Cell; 2018 Apr; 173(2):371-385.e18. PubMed ID: 29625053
[TBL] [Abstract][Full Text] [Related]
7. Predicting the functional consequences of somatic missense mutations found in tumors.
Carter H; Karchin R
Methods Mol Biol; 2014; 1101():135-59. PubMed ID: 24233781
[TBL] [Abstract][Full Text] [Related]
8. dbCID: a manually curated resource for exploring the driver indels in human cancer.
Yue Z; Zhao L; Cheng N; Yan H; Xia J
Brief Bioinform; 2019 Sep; 20(5):1925-1933. PubMed ID: 30016397
[TBL] [Abstract][Full Text] [Related]
9. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.
Bányai L; Trexler M; Kerekes K; Csuka O; Patthy L
Elife; 2021 Jan; 10():. PubMed ID: 33427197
[TBL] [Abstract][Full Text] [Related]
10. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
Andersson C; Fagman H; Hansson M; Enlund F
Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
[TBL] [Abstract][Full Text] [Related]
11. Annotation of Variant Data from High-Throughput DNA Sequencing from Tumor Specimens: Filtering Strategies to Identify Driver Mutations.
Sun S; Thorson JA; Murray SS
Methods Mol Biol; 2019; 1908():49-60. PubMed ID: 30649720
[TBL] [Abstract][Full Text] [Related]
12. Kin-Driver: a database of driver mutations in protein kinases.
Simonetti FL; Tornador C; Nabau-Moretó N; Molina-Vila MA; Marino-Buslje C
Database (Oxford); 2014; 2014():bau104. PubMed ID: 25414382
[TBL] [Abstract][Full Text] [Related]
13. DriverDBv2: a database for human cancer driver gene research.
Chung IF; Chen CY; Su SC; Li CY; Wu KJ; Wang HW; Cheng WC
Nucleic Acids Res; 2016 Jan; 44(D1):D975-9. PubMed ID: 26635391
[TBL] [Abstract][Full Text] [Related]
14. A decision support framework for genomically informed investigational cancer therapy.
Meric-Bernstam F; Johnson A; Holla V; Bailey AM; Brusco L; Chen K; Routbort M; Patel KP; Zeng J; Kopetz S; Davies MA; Piha-Paul SA; Hong DS; Eterovic AK; Tsimberidou AM; Broaddus R; Bernstam EV; Shaw KR; Mendelsohn J; Mills GB
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25863335
[TBL] [Abstract][Full Text] [Related]
15. Malignancy of Cancers and Synthetic Lethal Interactions Associated With Mutations of Cancer Driver Genes.
Wang X; Zhang Y; Han ZG; He KY
Medicine (Baltimore); 2016 Feb; 95(8):e2697. PubMed ID: 26937901
[TBL] [Abstract][Full Text] [Related]
16. Identification of constrained cancer driver genes based on mutation timing.
Sakoparnig T; Fried P; Beerenwinkel N
PLoS Comput Biol; 2015 Jan; 11(1):e1004027. PubMed ID: 25569148
[TBL] [Abstract][Full Text] [Related]
17. IMPACT web portal: oncology database integrating molecular profiles with actionable therapeutics.
Hintzsche JD; Yoo M; Kim J; Amato CM; Robinson WA; Tan AC
BMC Med Genomics; 2018 Apr; 11(Suppl 2):26. PubMed ID: 29697364
[TBL] [Abstract][Full Text] [Related]
18. Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes.
Cheng F; Zhao J; Zhao Z
Brief Bioinform; 2016 Jul; 17(4):642-56. PubMed ID: 26307061
[TBL] [Abstract][Full Text] [Related]
19. IDENTIFY CANCER DRIVER GENES THROUGH SHARED MENDELIAN DISEASE PATHOGENIC VARIANTS AND CANCER SOMATIC MUTATIONS.
Ma M; Wang C; Glicksberg BS; Schadt EE; Li SD; Chen R
Pac Symp Biocomput; 2017; 22():473-484. PubMed ID: 27896999
[TBL] [Abstract][Full Text] [Related]
20. Machine Learning Classification and Structure-Functional Analysis of Cancer Mutations Reveal Unique Dynamic and Network Signatures of Driver Sites in Oncogenes and Tumor Suppressor Genes.
Agajanian S; Odeyemi O; Bischoff N; Ratra S; Verkhivker GM
J Chem Inf Model; 2018 Oct; 58(10):2131-2150. PubMed ID: 30253099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
